Gerry Brunk

Gerry Brunk

Vermogen: - $ op 31-08-2026

57 jaar
Health Technology
Finance
Commercial Services

Profiel

Gerry Brunk is the founder of Lumira Capital Investment Management, Inc., founded in 2002, serving as Managing Partner since 2020.
Current jobs include Director at enGene, Inc. since 2017; Director at ActivBiotics, Inc.; Director at BAROnova, Inc.; Director at Endotronix, Inc.; Director at HistoSonics, Inc.; Director at Virginia Biotechnology Association since 2022; Director at Corvia Medical, Inc. since 2013; Director at Engage Therapeutics, Inc.; Director at Cyrano Therapeutics, Inc. since 2020; Director at Southeast Life Sciences; President, Secretary & Director at LAVA Medtech Acquisition Corp.
since 2021; and Independent Non-Executive Director at enGene Therapeutics, Inc. since 2023.
Former jobs include Director at AdipoGenix, Inc.; Director at Cardiac Dimensions, Inc.; Director at Pharmasset, Inc.; Director at MAKO Surgical Corp.; Director at Celtaxsys, Inc.; Director at Targanta Therapeutics, Inc.; Member at Credit Suisse (USA) LLC; Chief Operating Officer at ActiveCyte, Inc. from 2000 to 2002; Manager-Health Care Practice at The Boston Consulting Group, Inc. from 1994 to 1999; and Member-Investment Banking Group at Credit Suisse First Boston Corp.
from 1990 to 1992.
Education includes undergraduate degree from the University of Virginia and MBA from Stanford Graduate School of Business.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
16-06-2026 0 ( -.--% ) - $ 31-08-2026

Actieve functies van Gerry Brunk

BedrijvenFunctieBegin
LAVA MEDTECH ACQUISITION CORP. President 01-10-2021
ENGENE THERAPEUTICS INC. Directeur/Bestuurslid 08-08-2023
Oprichter 01-06-2002
Directeur/Bestuurslid 01-04-2022
Directeur/Bestuurslid 01-10-2017
Directeur/Bestuurslid -
Directeur/Bestuurslid 01-12-2020
Directeur/Bestuurslid -
Directeur/Bestuurslid -
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -

Eerdere bekende functies van Gerry Brunk

BedrijvenFunctieEinde
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░░░░ ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ervaring van Gerry Brunk in detail bekijken

Opleiding van Gerry Brunk

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

69

Eerstegraads connecties

25

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Commercial Services

Finance

Health Technology

Commercial Services

ActiveCyte, Inc.

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Commercial Services

  1. Beurs
  2. Insiders
  3. Gerry Brunk
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU